When it comes to health equity, traditional methods of gathering and analyzing data to address care gaps have been insufficient in terms of delivering meaningful insights. Historically, pharma companies have defined their brand strategy through the lens of the HCP, but the rapid and growing influence of patients and advocacy groups have changed that trajectory by driving strategy toward consumerism accompanied by a demand for a clear view into the value that justifies ever increasing drug costs. 

The move to patient-centricity has been further accelerated by advancements in artificial intelligence (AI) and technology, the shift to competitive specialty product portfolios, and a recognition that meeting the needs of every patient is a requirement for long-term success which brings with it an increasing need for a broader and highly focused lens on health equity. 

Read the fact sheet to learn how access to health equity data, insights, and reporting can support and accelerate commercial success.